ambroxol has been researched along with Cough in 19 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol, oral solution, versus Ascoril Expectorant, syrup (combination of bromhexine, guaifenesin, and salbutamol) in the treatment of productive cough in adult patients with acute bronchitis." | 9.69 | [Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronch ( Esaulova, NA; Leshchenko, IV; Viktorova, IA; Zaitsev, AA, 2023) |
| "This study was designed to examine the efficacy and tolerability of ambroxol (Ambrosol) on the symptomatology of chronic bronchitis among in- and out-patients." | 9.08 | [Clinical evaluation of efficacy and tolerance of oral treatment with ambroxol in patients with chronic bronchitis]. ( Michnar, M; Milanowski, J, 1996) |
| "Twenty-three patients with exacerbations of chronic bronchitis were divided in two groups in a randomized fashion receiving either amoxicillin 1500 mg/d (n = 13) or amoxicillin 1500 mg/d associated with the mucolytic drug ambroxol 90 mg/d (n = 10)." | 9.06 | Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis. ( Corazza, C; Fernández, M; Guerreiro, RB; Peralta, J; Poderoso, JJ; Wiemeyer, JC, 1987) |
| " Ambroxol hydrochloride (AH), a respiratory tract lubricant and expectorant, is often used to treat chronic respiratory diseases, such as bronchial asthma, emphysema, tuberculosis, and cough." | 8.31 | Baicalin/ambroxol hydrochloride combined dry powder inhalation formulation targeting lung delivery for treatment of idiopathic pulmonary fibrosis: Fabrication, characterization, pharmacokinetics, and pharmacodynamics. ( Deng, X; Guo, P; He, J; Jia, B; Li, J; Liu, Z; Peng, H; Pi, J; Qi, D; Zhang, Y, 2023) |
| "To evaluate the efficacy and safety of Bronchosol® herbal syrup in comparison to ambroxol preparations in the treatment of acute bronchitis in adult patients." | 7.81 | [Efficacy and safety of acute bronchitis treatment in adults--a comparison of Bronchosol® syrup and synthetic preparations with ambroxol. Results of observational study]. ( Fal, AM; Schönknecht, K, 2015) |
| "We examined the involvement of tetrodotoxin (TTX)-resistant sodium channels in the peripheral mechanisms of the cough reflex in mice." | 7.77 | Possible involvement of tetrodotoxin-resistant sodium channels in cough reflex. ( Asato, M; Hayashi, SS; Ishikawa, Y; Kamei, J; Nakanishi, Y; Ohsawa, M, 2011) |
| "This study was designed to evaluate the "real life" behavior of consumers with non-prescription access to an ambroxol cough syrup with special focus on tolerability and the pattern of product usage." | 7.73 | Safety and usage pattern of an over-the-counter ambroxol cough syrup: a community pharmacy-based cohort study. ( Gillissen, A; Hämmerlein, A; Hinkel, U; Schulz, M; Weis, G, 2006) |
| "To evaluate the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol, oral solution, versus Ascoril Expectorant, syrup (combination of bromhexine, guaifenesin, and salbutamol) in the treatment of productive cough in adult patients with acute bronchitis." | 5.69 | [Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronch ( Esaulova, NA; Leshchenko, IV; Viktorova, IA; Zaitsev, AA, 2023) |
| "Rengalin liquid formulation on the basis of antibodies to bradikinin histamine and morphine was specially designed for the treatment of cough in children." | 5.19 | [Rengalin, a novel drug for treatment of cough in children. Intermediate data on multicentre, comparative randomized clinical trial]. ( Baltserovich, NB; Galustyan, AN; Geppe, NA; Kamaev, AV; Kondyurina, EG; Laleko, SL; Lazareva, SG; Melnikova, IM; Mikhalkova, EV; Pak, TE; Perminova, OA; Sabitov, AU; Spivakovsky, YM; Zhiglinskaya, OV, 2014) |
| "This study was designed to examine the efficacy and tolerability of ambroxol (Ambrosol) on the symptomatology of chronic bronchitis among in- and out-patients." | 5.08 | [Clinical evaluation of efficacy and tolerance of oral treatment with ambroxol in patients with chronic bronchitis]. ( Michnar, M; Milanowski, J, 1996) |
| "Twenty-three patients with exacerbations of chronic bronchitis were divided in two groups in a randomized fashion receiving either amoxicillin 1500 mg/d (n = 13) or amoxicillin 1500 mg/d associated with the mucolytic drug ambroxol 90 mg/d (n = 10)." | 5.06 | Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis. ( Corazza, C; Fernández, M; Guerreiro, RB; Peralta, J; Poderoso, JJ; Wiemeyer, JC, 1987) |
| " Ambroxol hydrochloride (AH), a respiratory tract lubricant and expectorant, is often used to treat chronic respiratory diseases, such as bronchial asthma, emphysema, tuberculosis, and cough." | 4.31 | Baicalin/ambroxol hydrochloride combined dry powder inhalation formulation targeting lung delivery for treatment of idiopathic pulmonary fibrosis: Fabrication, characterization, pharmacokinetics, and pharmacodynamics. ( Deng, X; Guo, P; He, J; Jia, B; Li, J; Liu, Z; Peng, H; Pi, J; Qi, D; Zhang, Y, 2023) |
| "Nine hundred sixty-five pharmacy customers purchasing one of four branded ambroxol formulations (extended release capsules, adult syrup, pediatric syrup and soft pastilles) filled a questionnaire including a patient-adapted version of the Bronchitis Severity Scale, several questions on degree of impairment by acute cough, time to onset of symptom relief and duration of treatment." | 3.88 | Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulations. ( Beeh, KM; Gräter, H; Kardos, P; Michel, MC; Mueck, T; Sent, U, 2018) |
| "To evaluate the efficacy and safety of Bronchosol® herbal syrup in comparison to ambroxol preparations in the treatment of acute bronchitis in adult patients." | 3.81 | [Efficacy and safety of acute bronchitis treatment in adults--a comparison of Bronchosol® syrup and synthetic preparations with ambroxol. Results of observational study]. ( Fal, AM; Schönknecht, K, 2015) |
| "We examined the involvement of tetrodotoxin (TTX)-resistant sodium channels in the peripheral mechanisms of the cough reflex in mice." | 3.77 | Possible involvement of tetrodotoxin-resistant sodium channels in cough reflex. ( Asato, M; Hayashi, SS; Ishikawa, Y; Kamei, J; Nakanishi, Y; Ohsawa, M, 2011) |
| "The aim of this study was to follow the changes in the cough reflex after administration of ambroxol in the dose of 10 mg/kg body weight." | 3.70 | [Ambroxol and protective reflexes of the respiratory tract]. ( Franová, S; Nemceková, E; Nosálóvá, G, 1998) |
| "Results." | 2.79 | [Therapeutic modalities for the management of cough associated with acute respiratory viral infection, effective in an otolaryngologist's practice]. ( Korostelev, SA; Mitiuk, AM; Ovchinnikov, AI; Paniakina, MA, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (26.32) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Zaitsev, AA | 1 |
| Leshchenko, IV | 1 |
| Esaulova, NA | 1 |
| Viktorova, IA | 1 |
| Qi, D | 1 |
| Jia, B | 1 |
| Peng, H | 1 |
| He, J | 1 |
| Pi, J | 1 |
| Guo, P | 1 |
| Zhang, Y | 1 |
| Deng, X | 1 |
| Li, J | 1 |
| Liu, Z | 1 |
| Elgamasy, S | 1 |
| Kamel, MG | 1 |
| Ghozy, S | 1 |
| Khalil, A | 1 |
| Morra, ME | 1 |
| Islam, SMS | 1 |
| Kardos, P | 1 |
| Beeh, KM | 1 |
| Sent, U | 1 |
| Mueck, T | 1 |
| Gräter, H | 1 |
| Michel, MC | 1 |
| Dhar, R | 1 |
| Ovchinnikov, AI | 1 |
| Paniakina, MA | 1 |
| Korostelev, SA | 1 |
| Mitiuk, AM | 1 |
| Geppe, NA | 1 |
| Kondyurina, EG | 1 |
| Galustyan, AN | 1 |
| Pak, TE | 1 |
| Baltserovich, NB | 1 |
| Zhiglinskaya, OV | 1 |
| Kamaev, AV | 1 |
| Lazareva, SG | 1 |
| Laleko, SL | 1 |
| Melnikova, IM | 1 |
| Mikhalkova, EV | 1 |
| Perminova, OA | 1 |
| Sabitov, AU | 1 |
| Spivakovsky, YM | 1 |
| Fal, AM | 1 |
| Schönknecht, K | 1 |
| Chang, CY | 1 |
| Sachs, HC | 1 |
| Lee, CE | 1 |
| Yakoot, M | 1 |
| Salem, A | 1 |
| Omar, AM | 1 |
| Kamei, J | 1 |
| Nakanishi, Y | 1 |
| Ishikawa, Y | 1 |
| Hayashi, SS | 1 |
| Asato, M | 1 |
| Ohsawa, M | 1 |
| Schulz, M | 1 |
| Hämmerlein, A | 1 |
| Hinkel, U | 1 |
| Weis, G | 1 |
| Gillissen, A | 1 |
| Berni, M | 1 |
| Collina, A | 1 |
| Zavattini, G | 1 |
| Michnar, M | 1 |
| Milanowski, J | 1 |
| Nemceková, E | 1 |
| Nosálóvá, G | 1 |
| Franová, S | 1 |
| Renovanz, HD | 2 |
| von Seefeld, H | 1 |
| Papendick, U | 1 |
| Heissler, K | 1 |
| Schuster, D | 1 |
| Germouty, J | 1 |
| Jirou-Najou, JL | 1 |
| Peralta, J | 1 |
| Poderoso, JJ | 1 |
| Corazza, C | 1 |
| Fernández, M | 1 |
| Guerreiro, RB | 1 |
| Wiemeyer, JC | 1 |
1 review available for ambroxol and Cough
| Article | Year |
|---|---|
Role of mucolytics in wet cough.
Topics: Ambroxol; Asthma; Bronchodilator Agents; Cholinergic Antagonists; Cough; Cystic Fibrosis; Expectoran | 2013 |
7 trials available for ambroxol and Cough
| Article | Year |
|---|---|
[Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronch
Topics: Acute Disease; Adult; Albuterol; Ambroxol; Bromhexine; Bronchitis; Cough; Drug Combinations; Expecto | 2023 |
[Therapeutic modalities for the management of cough associated with acute respiratory viral infection, effective in an otolaryngologist's practice].
Topics: Acute Disease; Adult; Albuterol; Ambroxol; Bromhexine; Bronchodilator Agents; Cough; Drug Combinatio | 2014 |
[Rengalin, a novel drug for treatment of cough in children. Intermediate data on multicentre, comparative randomized clinical trial].
Topics: Administration, Oral; Adolescent; Ambroxol; Antibodies, Neutralizing; Antitussive Agents; Bradykinin | 2014 |
Clinical efficacy of farcosolvin syrup (ambroxol-theophylline-guaiphenesin mixture) in the treatment of acute exacerbation of chronic bronchitis.
Topics: Aged; Ambroxol; Bronchitis, Chronic; Bronchodilator Agents; Cough; Drug Combinations; Egypt; Expecto | 2010 |
[Clinical evaluation of efficacy and tolerance of oral treatment with ambroxol in patients with chronic bronchitis].
Topics: Administration, Oral; Adult; Aged; Ambroxol; Anti-Bacterial Agents; Bronchitis; Chronic Disease; Cou | 1996 |
Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses.
Topics: Adult; Aged; Ambroxol; Bromhexine; Bronchial Diseases; Clinical Trials as Topic; Cough; Dose-Respons | 1987 |
Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis.
Topics: Adult; Aged; Aged, 80 and over; Ambroxol; Amoxicillin; Blood Gas Analysis; Bromhexine; Bronchitis; C | 1987 |
11 other studies available for ambroxol and Cough
| Article | Year |
|---|---|
Baicalin/ambroxol hydrochloride combined dry powder inhalation formulation targeting lung delivery for treatment of idiopathic pulmonary fibrosis: Fabrication, characterization, pharmacokinetics, and pharmacodynamics.
Topics: Administration, Inhalation; Ambroxol; Cough; Dry Powder Inhalers; Humans; Idiopathic Pulmonary Fibro | 2023 |
First case of focal epilepsy associated with SARS-coronavirus-2.
Topics: Acetaminophen; Acetylcysteine; Aged; Ambroxol; Anticonvulsants; Cough; COVID-19; COVID-19 Drug Treat | 2020 |
Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulations.
Topics: Adolescent; Adult; Ambroxol; Bronchitis; Child; Child, Preschool; Cough; Dosage Forms; Drug Compound | 2018 |
[Efficacy and safety of acute bronchitis treatment in adults--a comparison of Bronchosol® syrup and synthetic preparations with ambroxol. Results of observational study].
Topics: Acute Disease; Adult; Ambroxol; Antitussive Agents; Bronchitis; Cough; Expectorants; Female; Humans; | 2015 |
Unexpected infant deaths associated with use of cough and cold medications.
Topics: Ambroxol; Cause of Death; Common Cold; Cough; Expectorants; Humans; Infant; Nonprescription Drugs | 2009 |
Possible involvement of tetrodotoxin-resistant sodium channels in cough reflex.
Topics: Ambroxol; Animals; Antitussive Agents; Cough; Dose-Response Relationship, Drug; Male; Mice; Mice, In | 2011 |
Safety and usage pattern of an over-the-counter ambroxol cough syrup: a community pharmacy-based cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambroxol; Child; Cohort Studies; Cough; Expectorants; Fe | 2006 |
[Ambroxol in bronchopulmonary pathology in children].
Topics: Ambroxol; Bromhexine; Bronchial Diseases; Bronchitis; Carbocysteine; Child; Child, Preschool; Cough; | 1983 |
[Ambroxol and protective reflexes of the respiratory tract].
Topics: Ambroxol; Animals; Cats; Cough; Expectorants; Guinea Pigs; Muscle Contraction; Muscle, Smooth; Refle | 1998 |
[Tussometry. II. Tussometry for the monitoring of drug effects].
Topics: Ambroxol; Antitussive Agents; Bronchodilator Agents; Clenbuterol; Cough; Humans; Methods; Morpholine | 1979 |
[Drug evaluation in children with special reference to functional parameters in asthma therapy].
Topics: Ambroxol; Asthma; Child; Child, Preschool; Cough; Drug Evaluation; Human Rights; Humans; Infant; Inf | 1977 |